Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 11:15AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.60 Insider Own0.83% Shs Outstand181.91M Perf Week-6.68%
Market Cap7.53B Forward P/E- EPS next Y-0.56 Insider Trans0.00% Shs Float180.78M Perf Month-8.56%
Income-465.95M PEG- EPS next Q-0.31 Inst Own47.14% Short Float7.34% Perf Quarter-34.27%
Sales342.80M P/S21.96 EPS this Y18.98% Inst Trans19.01% Short Ratio11.41 Perf Half Y-32.63%
Book/sh6.39 P/B6.47 EPS next Y53.33% ROA-31.22% Short Interest13.26M Perf Year-41.07%
Cash/sh7.15 P/C5.78 EPS next 5Y- ROE-51.28% 52W Range38.60 - 77.32 Perf YTD-31.37%
Dividend Est.- P/FCF- EPS past 5Y-168.48% ROI-31.15% 52W High-46.59% Beta0.10
Dividend TTM- Quick Ratio5.57 Sales past 5Y50.60% Gross Margin52.35% 52W Low6.98% ATR (14)2.14
Dividend Ex-Date- Current Ratio5.66 EPS Y/Y TTM20.41% Oper. Margin-127.12% RSI (14)41.62 Volatility5.23% 5.38%
Employees1826 Debt/Eq0.29 Sales Y/Y TTM231.84% Profit Margin-135.92% Recom1.26 Target Price82.33
Option/ShortYes / Yes LT Debt/Eq0.28 EPS Q/Q51.58% Payout- Rel Volume0.32 Prev Close41.50
Sales Surprise-34.38% EPS Surprise17.31% Sales Q/Q158.67% EarningsMay 13 BMO Avg Volume1.16M Price41.29
SMA20-3.89% SMA50-9.51% SMA200-28.99% Trades Volume115,384 Change-0.50%
Date Action Analyst Rating Change Price Target Change
Jun-17-24Initiated Truist Buy $88
May-24-24Reiterated H.C. Wainwright Buy $86 → $73
May-23-24Initiated Deutsche Bank Buy $60
Apr-17-24Upgrade Scotiabank Sector Perform → Sector Outperform $65
Apr-03-24Initiated Cantor Fitzgerald Overweight $82
Mar-13-24Initiated Raymond James Outperform $86
Dec-19-23Initiated Scotiabank Sector Perform
Nov-06-23Initiated Goldman Buy $90.09
May-25-23Initiated William Blair Mkt Perform $64
May-22-23Initiated Daiwa Securities Buy
Jun-03-24 04:00PM
May-29-24 08:00AM
May-23-24 05:00PM
May-15-24 08:19AM
May-14-24 09:23AM
06:54AM Loading…
May-13-24 11:53AM
May-09-24 08:52AM
Apr-25-24 11:28AM
01:37PM Loading…
Apr-22-24 01:37PM
Apr-11-24 08:00AM
Apr-08-24 08:48AM
Apr-05-24 11:36PM
Apr-03-24 05:39AM
Mar-29-24 05:09AM
Mar-19-24 08:30AM
Mar-17-24 08:50AM
Mar-15-24 03:15PM
Mar-12-24 08:20AM
Mar-11-24 07:00AM
Feb-23-24 07:15AM
Feb-13-24 08:00AM
02:41AM Loading…
Feb-07-24 02:41AM
Jan-22-24 08:34PM
Jan-03-24 08:30AM
Jan-02-24 10:29AM
Dec-26-23 06:56PM
Dec-19-23 11:40AM
Dec-11-23 07:30PM
Nov-28-23 02:51PM
Nov-24-23 04:02PM
Nov-20-23 11:09PM
Nov-16-23 05:50AM
Nov-14-23 10:47AM
Nov-13-23 08:30AM
Nov-07-23 08:30AM
Nov-02-23 09:17AM
Oct-30-23 10:39AM
Oct-20-23 05:10AM
Oct-03-23 05:52AM
Sep-21-23 08:00AM
Aug-16-23 02:40AM
Aug-15-23 06:00AM
Aug-14-23 08:36AM
Aug-10-23 08:14AM
Aug-07-23 06:57PM
Aug-03-23 08:30AM
Aug-02-23 09:56AM
Jul-25-23 02:45AM
Jun-29-23 02:00AM
Jun-07-23 08:35AM
Jun-06-23 04:30PM
Jun-05-23 11:04AM
Jun-02-23 04:01PM
May-25-23 08:30AM
May-23-23 03:14PM
May-18-23 08:30AM
May-16-23 08:35AM
May-11-23 04:01PM
May-08-23 08:30AM
May-03-23 10:25PM
May-01-23 09:25AM
Apr-21-23 04:03PM
Apr-20-23 11:04AM
Apr-19-23 07:22PM
Apr-11-23 08:30AM
Apr-03-23 04:01PM
Apr-02-23 09:49AM
Apr-01-23 09:45AM
Mar-30-23 04:01PM
Mar-29-23 08:54PM
Mar-24-23 02:47AM
Feb-25-23 11:38AM
Feb-24-23 08:30AM
Feb-21-23 08:30AM
Jan-27-23 09:54AM
Jan-03-23 04:01PM
Jan-02-23 04:45AM
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.